Vygon Acquires Macatt Medica

Peruvian distributor of single-use medical devices. Takeover will enable Vygon to build on its presence in South America, particularly in enteral nutrition sector.

Vygon, a specialist single-use medical devices group, today announces the acquisition of Macatt Medica, a distribution company located in Lima, Peru.

The company distributes the majority of Vygon’s products in Peru, including a wide range of enteral nutrition products. The financial terms of the agreement have not been disclosed.

With this acquisition, Macatt Medica will become a fully owned subsidiary; boosting Vygon’s presence in South America. Its 21 employees will be joining Vygon’s staff.

“We are delighted that Macatt is joining the extended Vygon family and, in particular, that this will enable us to strengthen our presence on the market for active medical devices,” said Michel Hanania, vice president for the Latin America region at Vygon.

Hanania added, “This product range will complement the one that we have developed alongside our branch in Colombia, in the area of single-use ‘consumable’ products, which will enable us to offer a comprehensive range of products to our South American client base.”

“It’s a big step forward for Macatt to become Vygon’s Peru subsidiary; we are already working closely, distributing its products; this takeover is a natural progression for our company,” said Manuel Catalan, CEO of Macatt Medica. “This acquisition is an opportunity for Macatt to boost its presence on the distribution market for enteral nutrition products, while at the same time becoming part of a group which shares the same values as us.”

Founded in 1997, Macatt Medica has been distributing Vygon products since 2010. Its turnover rose to €1.7 million ($1.9M) in 2021.

SourceVygon

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version